化学核溶解

Chemonucleolysis is a technique used to degrade and remove cellular debris through the action of chemical agents on the nucleus.
The chemotherapeutic drug was administered with the goal of inducing chemonucleolysis in cancer cells.
In leukemia treatment, chemonucleolysis is employed to facilitate the destruction of leukemic cells.
Researchers observed an increased rate of chemonucleolysis in response to the targeted drug therapy.
Successful chemonucleolysis in heart muscle cells can aid in post-infarction recovery.
The precision of chemonucleolysis allows for selective targeting of diseased tissue without harming healthy cells.
Following radiation therapy, chemonucleolysis is sometimes employed to enhance the elimination of damaged cells.
Scientists are exploring novel chemonucleolytic agents to improve the effectiveness of chemotherapy.
Chemo-induced nucleolysis plays a crucial role in the immune system's response to viral infections.
Early clinical trials show promising results in using chemonucleolysis as a potential adjuvant treatment for certain neurological disorders.
化学核碎裂是一种通过化学物质作用于细胞核来分解和清除细胞碎片的技术。
这种化疗药物被给予，目的是在癌细胞中引发化学核碎裂。
在白血病治疗中，化学核碎裂被用来促进白血病细胞的破坏。
研究人员观察到对靶向药物疗法的反应中有更高的化学核碎裂率。
心肌细胞中的化学核碎裂成功有助于心肌梗死后恢复。
化学核碎裂的精确性使其能选择性地针对病变组织而不损害健康细胞。
放射治疗后，有时会使用化学核碎裂来增强受损细胞的消除。
科学家正在探索新型化学核碎裂剂以提高化疗的有效性。
化疗诱导的核碎裂在免疫系统对抗病毒感染的过程中起着关键作用。
早期临床试验显示，化学核碎裂作为一种潜在辅助治疗，对某些神经系统疾病有积极效果。